A-New Bio Inc. / ANB

Advancing the Future of Cell Manufacturing

ANB develops proprietary culture technologies designed to support the long-term maintenance and scalable expansion of stem cells and progenitor cells.

Technology Platforms

ANB is developing proprietary culture technologies for blood stem cell and avian stem cell platforms. The company’s work focuses on maintaining cellular quality, functional potential, and manufacturing consistency.

Blood Stem Cell Technologies

Culture systems designed to support the maintenance and expansion of blood-forming stem and progenitor cells for future research and therapeutic applications.

Avian Stem Cell Technologies

Stem cell platforms supporting avian genetic engineering, agricultural biotechnology, and next-generation research models.

Applications & Partnerships

ANB is developing proprietary culture technologies that support the development and manufacturing of advanced cellular products.

Research Reagents Cell Therapy Manufacturing Clinical-Grade Cellular Starting Materials Strategic Partnerships Licensing Opportunities

News & Updates

USDA APHIS Poultry Innovation Grant

A-New Bio Inc. was selected for work supporting innovation in poultry biotechnology and avian influenza resistance.

Avian Stem Cell Platform

ANB continues to advance avian embryonic stem cell technologies for genetic engineering and agricultural biotechnology applications.

Founding Leadership

Daping Xia Co-Founder & Chief Executive Officer

Leads corporate strategy, business development, financing strategy, partnerships, and company operations.

Qilong Ying, Ph.D. Co-Founder & Chief Scientific Officer

Leads scientific vision and platform innovation across stem cell culture technologies and translational research programs.

Daniel McKim, Ph.D. Founding Executive & Chief Operating Officer

Leads operational execution, translational development, program planning, and research-to-product advancement.

Zheng Guo, Ph.D. Founding Scientist

Contributes to platform development, experimental execution, and stem cell technology innovation.

Contact ANB

For partnership, research collaboration, business development, or investor inquiries, please contact: